Ironwood Pharmaceuticals | IRWD - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
Acadia Pharmaceuticals USD 3.98M 22.34M 2026-03
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Almirall EUR 30.32M 22M 2025-12
Alnylam Pharmaceuticals USD 177.81M 43.85M 2026-06
Amarin USD -852K 7.26M 2025-12
Ardelyx USD -37.6M 37.2M 2026-03
Astellas Pharma JPY 48.02B 85.93B 2026-03
AstraZeneca USD 4.81B 894M 2026-06
Charles River Laboratories USD -294.1M 464.13M 2025-12
Coherus Biosciences USD -46.35M 90.86M 2025-12
Halozyme Therapeutics USD 180.33M 281.18M 2026-03
Incyte USD 343.6M 46.34M 2026-03
Ironwood Pharmaceuticals USD 68.02M 30.2M 2025-09
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
Lexicon Pharmaceuticals USD -12.77M 16.02M 2025-09
MacroGenics USD -36.77M 21.84M 2026-03
Moderna USD -1.33B 535M 2026-03
Myriad Genetics USD 4.6M 3.4M 2025-12
Pacira USD 571K 8.95M 2025-12
PTC Therapeutics USD -2.46M 136.62M 2026-03
Puma Biotechnology USD 20.61M 24.76M 2024-09
Sarepta Therapeutics USD 343.17M 750.85M 2026-03
Takeda JPY 162.72B 215.2B 2026-06
Ultragenyx Pharmaceutical USD -184M 56M 2026-03
Vanda Pharmaceuticals USD -22.92M 16.68M 2024-12